Search for: "Bristol Myers Squibb Manufacturing Company"
Results 1 - 20
of 162
Sort by Relevance
|
Sort by Date
5 Mar 2024, 11:47 am
PLAINTIFF COURT AND DATE OF COMPLAINT SELECTED DRUGS (FOR YEAR 2026) Bristol Myers Squibb D.N.J. (16 June 2023) Eliquis Novartis D.N.J. (1 Sept. 2023) Entresto J&J’s Janssen Pharms. [read post]
29 Jan 2024, 4:35 pm
What we've manufactured is rhino horn powder. [read post]
4 Oct 2023, 10:00 pm
The Plaintiffs in the remaining five lawsuits (Merck, Bristol Myers Squibb, PhRMA and other trade associations, Janssen pharmaceutical, and Boehringer Ingelheim) might similarly amend their complaints to note that their drugs were in fact selected, and that they were compelled to sign contracts with the CMS. [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
3 Apr 2023, 6:00 am
The Court’s ruling clarified its decisions in Bristol-Myers Squibb Co. v. [read post]
20 Mar 2023, 7:52 am
Bristol-Myers Squibb Co., 2023 WL 2519857, SCAP-21-0000363, --- P.3d ---- (Hawai’i Mar. 15, 2023) The state sued two pharmaceutical companies for violating Hawai‘i’s Unfair or Deceptive Acts or Practices law (UDAP) by misleading the public about the safety and efficacy of their antiplatelet drug, Plavix. [read post]
6 Jan 2023, 2:33 pm
Bristol-Myers Squibb paying $75 million to resolve allegations was the seventh largest Healthcare Fraud recovery on last year’s list. [read post]
26 Oct 2022, 3:17 am
(Nov. 24, 2021), https://ag.ny.gov/press-release/2021/attorney-general-james-secures-51-million-judgment-against-new-york-city-stem. [5] $834 Million Order Entered in Hawai‘i State Court against Bristol-Myers Squibb and Sanofi for Failing to Investigate and Disclose Ineffectiveness of Plavix®, Dept. of the Att’y Gen. [read post]
19 Jul 2022, 2:59 pm
Courts do not require companies to be pessimistic in assessing arguably negative results; they merely require that companies be honest in their statements and forthcoming with the relevant underlying facts. [read post]
11 Jan 2022, 11:45 am
Bristol-Myers Squibb is not the first manufacturer to run into issues with the program. [read post]
11 Jan 2022, 11:45 am
Bristol-Myers Squibb is not the first manufacturer to run into issues with the program. [read post]
18 Aug 2021, 12:07 pm
California Attorney General Rob Bonta today announced a $75 million nationwide settlement with global pharmaceutical company Bristol Myers Squibb (BMS), resolving allegations that BMS underpaid the drug rebates owed to Medi-Cal and other state Medicaid programs. [read post]
25 Jun 2021, 4:15 am
A group of intellectual property professors; GlaxoSmithKline plc; and Biogen Inc., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
16 Apr 2021, 5:00 am
Supreme Court’s previous rejection in Bristol-Myers of specific jurisdiction over claims by non-resident plaintiffs against a non-resident company whose product allegedly injured the plaintiffs. [read post]
2 Apr 2021, 9:45 am
How Bristol-Myers Squibb and other Pharma Companies Misrepresent Average Manufacturer Prices This week’s settlement resolves allegations that Bristol-Myers Squibb improperly calculated AMPs for many of its drugs in order to reduce the rebates it owed – and increase the share paid by Medicaid. [read post]
26 Mar 2021, 5:56 pm
What is of particular interest to our readers is the Court’s re-emphasis of the meaning of Bristol-Myers Squibb Co. v. [read post]
25 Mar 2021, 11:33 am
With Specific Jurisdiction, the Court’s recent decision in Bristol-Myers Squibb Co. v. [read post]
15 Dec 2020, 5:00 am
Supreme Court opinions, the most recent of which was in the case of Bristol-Myers Squibb v. [read post]
22 Oct 2020, 5:39 am
The Court reviewed several notable United States Supreme Court Opinions, the most recent of which was in the case of Bristol-Myers Squibb Co. v. [read post]
